Marc Martens

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study

Allan T. van Oosterom, Ian Judson, Jaap Verweij et al. · The Lancet · 2001 · 1.3K citations

Medicine, Oncology, Pharmacotherapy +12

18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)

Sigrid Stroobants, J. Goeminne, M. Seegers et al. · European Journal of Cancer · 2003 · 526 citations

Medicine, Nuclear Medicine, Oncology +10

Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors

Giuseppe Giaccone, J.L. González-Larriba, A.T. van Oosterom et al. · Annals of Oncology · 2004 · 58 citations · Full text

Medicine, Oncology, Pharmacology +14

Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer

Hannelore Denys, Corina L. Martinez-Mena, Marc Martens et al. · Breast Cancer Research and Treatment · 2020 · 42 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Docetaxel and gemcitabine combination therapy in advanced transitional cell carcinoma of the urothelium: results of a phase II and pharmacologic study

Herlinde Dumez, Marc Martens, Johan Selleslach et al. · Anti-Cancer Drugs · 2006 · 22 citations

Medicine, Oncology, Pharmacology +12